Toggle navigation
Browse
Home
People
Departments & Colleges
Research
Research Area Overlaps
Outcomes when stage IV non-small cell lung cancer (NSCLC4) patients (pts) harboring oncogenic drivers (OD) are treated initially without tyrosine kinase inhibitors (TKI)
Meeting Abstract (Web of Science)
Overview
Research
Additional Document Info
View All
Overview
cited authors
Choksi, R.; Smith, R.; Johnson, M.; Gordan, L.; Xue, M.; Varughese, P.; Dorrow, N.; Wang, B.; Vaidya, V.; Vasudevan, A.; Gart, M.; Gierman, H.; Scott, J.
publication date
September 1, 2022
webpage
Web of Science
published in
ANNALS OF ONCOLOGY
Journal
Research
category
ONCOLOGY
Category
Additional Document Info
start page
S1057
end page
S1058
volume
33
issue
7